Skip to content
Screener

Ingevity NGVT Q3 2025 earnings

Reported November 5, 2025 · After market close

Revenue$333.1MBeat by $75.8M
EPS$1.31Beat by $0.63
Revenue estimate$257.3M
EPS estimate$0.68

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$303.9M
EPS estimate$1.56

Financials

Q3 2025

Income statement

See full
Revenue$333.1M-0.2%
Gross profit$133.9M+1.7%
Net income$43.5M+141%
EPS (diluted)$1.18+140%

Balance sheet

See full
Cash & equivalents$83.4M-45.7%
Total debt$1.4B-15.9%
Total equity$138.1M-35.6%
Total assets$1.8B-17.1%

Cash flow

See full
Operating cash flow$129.7M+179%
CapEx$11.9M-33.9%
Free cash flow$117.8M+313%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$2.01B+42.0%
Enterprise value$3.32B+13.8%
P/S1.7×+0.3×

Profitability

See full
Gross margin40%+3.6pp
Net margin-6.8%-3.2pp
FCF margin19.8%+17.1pp

Returns & leverage

See full
Return on equity-46.8%-17.8pp
Debt / equity10.1×+2.4×
Current ratio1.3×-0.5×

Segments

By segment

See full
Performance Materials$155.0M+2.6%
Performance Chemicals$139.9M+4.5%
Advanced Polymer Technologies segment$38.2M-21.7%

By geography

See full
North America$205.1M+6.9%
Asia Pacific$73.3M-10.8%
South America$13.3M-21.3%

FAQ

When did Ingevity report Q3 2025 earnings?
Ingevity (NGVT) reported Q3 2025 earnings on November 5, 2025 after market close.
What were Ingevity's Q3 2025 revenue and EPS?
Ingevity reported revenue of $333.1M and eps of $1.31 for Q3 2025.
Did Ingevity beat estimates in Q3 2025?
Revenue beat the consensus estimate of $257.3M by $75.8M. EPS beat the consensus estimate of $0.68 by $0.63.
How did Ingevity's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 11.6% from $376.9M a year earlier and eps grew 19.1% from $1.10.
Where can I find Ingevity's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001653477-25-000124) and the 10-Q periodic report (0001653477-25-000127) directly on SEC EDGAR. The filing index links above go to sec.gov.